BBA
Baker Bros. Advisors Portfolio holdings
AUM
$10.3B
This Quarter Return
+17.29%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$11B
AUM Growth
+$11B
(+16%)
Cap. Flow
+$82.4M
Cap. Flow
% of AUM
0.75%
Top 10 Holdings %
Top 10 Hldgs %
83.4%
Holding
143
New
7
Increased
14
Reduced
17
Closed
6
Top Buys
| 1 |
AMRN
Amarin Corp
AMRN
|
$63.3M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$46.5M |
| 3 |
Acadia Pharmaceuticals
ACAD
|
$41.4M |
| 4 |
Neurogene
NGNE
|
$37.2M |
| 5 |
Exelixis
EXEL
|
$30M |
Top Sells
| 1 |
XNPT
XENOPORT, INC.
XNPT
|
$24.5M |
| 2 |
MDVN
MEDIVATION, INC.
MDVN
|
$19.9M |
| 3 |
BioCryst Pharmaceuticals
BCRX
|
$17.8M |
| 4 |
Novavax
NVAX
|
$17.3M |
| 5 |
Insmed
INSM
|
$16M |
Sector Composition
| 1 | Healthcare | 82.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
GWPH
126
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| – | – |
-15,000
| Closed | -$1.37M |
|
|
127
Novavax
NVAX
$1.2B
| – | – |
-2,379,254
| Closed | -$17.3M |
|
128
Curis
CRIS
$21.5M
| – | – |
-1,999,303
| Closed | -$3.12M |
|
129
Aurinia Pharmaceuticals
AUPH
$1.58B
| – | – |
-711,499
| Closed | -$2.12M |
|